NASDAQ: CBIOCrescent Biopharma Inc Stock Ownership - Who owns Crescent Biopharma?
Insider buying vs selling
Have Crescent Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | 2026-07-16 | 853,450 | $14.50 | $12.38MBuy |
| Joshua T. Brumm | Chief Executive Officer | 2026-06-22 | 42,305 | $17.99 | $761.07kSell |
| Richard William Scalzo | Chief Financial Officer | 2026-06-22 | 1,112 | $17.99 | $20.00kSell |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 2026-06-22 | 1,218 | $17.99 | $21.91kSell |
| Ellie Eunkyung Im | Chief Medical Officer | 2026-06-22 | 1,219 | $17.99 | $21.93kSell |
| Ryan Lynch | Treasurer Senior Vice President of Finance and Chief Accounting Officer. | 2026-06-22 | 465 | $17.99 | $8.37kSell |
| Jonathan McNeill | President and COO | 2026-06-22 | 20,549 | $17.99 | $369.68kSell |
| Jan Pinkas | Chief Scientific Officer | 2026-06-22 | 1,288 | $17.99 | $23.17kSell |
| Fairmount Funds Management LLC | Director | 2025-12-04 | 1,360,000 | $13.41 | $18.24MBuy |
CBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CBIO insiders and whales buy or sell their stock.
CBIO Shareholders
What type of owners hold Crescent Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Scott D. Sandell | 37.84% | 14,056,571 | $234.60M | Insider |
| M. James Barrett | 35.49% | 13,182,418 | $220.01M | Insider |
| Peter J. Barris | 35.49% | 13,182,418 | $220.01M | Insider |
| Siren LLC | 23.12% | 8,589,064 | $143.35M | Insider |
| Fairmount Funds Management LLC | 17.09% | 6,349,182 | $105.97M | Insider |
| Invus Public Equities LP | 17.01% | 6,317,565 | $105.44M | Insider |
| New Enterprise Associates 10 L P | 13.45% | 4,995,664 | $83.38M | Insider |
| New Enterprise Associates 13 LP | 11.02% | 4,093,377 | $68.32M | Insider |
| Sanofi | 3.21% | 1,193,625 | $19.92M | Insider |
| Michael A. Henos | 2.68% | 995,395 | $16.61M | Insider |
CBIO vs Biotech Stocks
Crescent Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.